title: Three phase 99Tcm (V)DMSA scintigraphy in Paget's disease: an indicator of pamidronate effect.
abstract: The use of three phase 99Tcm (V)DMSA scintigraphy is reported in a patient with Paget's disease of bone before and after intravenous pamidronate therapy. It was a useful modality for estimating the activity of Pagetoid lesions and the therapeutic effect of pamidronate, from a different aspect to bone scintigraphy. Three phase 99Tcm (V)DMSA scintigraphy evaluates both the blood flow and the metabolic activity of Pagetoid bone.
authors.affiliation: Department of Radiology and Nuclear Medicine, Kyoto University, Faculty of Medicine, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Kobayashi
authors.forename: C
authors.initials: C
authors.lastname: Shigeno
authors.forename: H
authors.initials: H
authors.lastname: Sakahara
authors.forename: T
authors.initials: T
authors.lastname: Yamamoto
authors.forename: M
authors.initials: M
authors.lastname: Hosono
authors.forename: R
authors.initials: R
authors.lastname: Fujimoto
authors.forename: J
authors.initials: J
authors.lastname: Konishi
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D006811:Humerus / Q000000981:diagnostic imaging; D008297:Male; D010001:Osteitis Deformans / Q000000981:diagnostic imaging* / Q000188:drug therapy; D000077268:Pamidronate; D011877:Radionuclide Imaging; D019783:Technetium Tc 99m Dimercaptosuccinic Acid; D016896:Treatment Outcome
chemical_list: D004164:Diphosphonates; D019783:Technetium Tc 99m Dimercaptosuccinic Acid; D000077268:Pamidronate